DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ANAFRANIL

« Back to Dashboard

All Clinical Trials for Anafranil

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00018200	Effect of Antidepressants on Back Pain	Completed	VA Office of Research and Development	Phase 2	1999-04-01	The purpose of this study is to determine whether different types of antidepressant medicines relieve back pain that has lasted at least six months on a daily basis. Study participants will be assigned to treatment with either a antidepressant acting on the serotonin system in the brain (fluoxetine), one acting on the noradrenaline system (desipramine, or to a control medication not expected to relieve pain (benztropine). Each participant will be seen at least nine times during their 12 weeks on medication. This is a phase 2/3, outpatient study.
NCT00466609	Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment	Completed	Conselho Nacional de Desenvolvimento Científico e Tecnológico	Phase 4	2007-05-01	This will be a controlled, randomized, double-blind and double-dummy study on the treatment augmentation strategy for obsessive compulsive disorder patients non-respondent to first line pharmacological treatment. The investigators will compare: fluoxetine maintenance at maximum dosage for additional 12 weeks; the association of fluoxetine with quetiapine; and the association of fluoxetine with clomipramine.
NCT00466609	Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment	Completed	Fundação de Amparo à Pesquisa do Estado de São Paulo	Phase 4	2007-05-01	This will be a controlled, randomized, double-blind and double-dummy study on the treatment augmentation strategy for obsessive compulsive disorder patients non-respondent to first line pharmacological treatment. The investigators will compare: fluoxetine maintenance at maximum dosage for additional 12 weeks; the association of fluoxetine with quetiapine; and the association of fluoxetine with clomipramine.
NCT00466609	Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment	Completed	Novartis	Phase 4	2007-05-01	This will be a controlled, randomized, double-blind and double-dummy study on the treatment augmentation strategy for obsessive compulsive disorder patients non-respondent to first line pharmacological treatment. The investigators will compare: fluoxetine maintenance at maximum dosage for additional 12 weeks; the association of fluoxetine with quetiapine; and the association of fluoxetine with clomipramine.
NCT00466609	Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment	Completed	University of Sao Paulo	Phase 4	2007-05-01	This will be a controlled, randomized, double-blind and double-dummy study on the treatment augmentation strategy for obsessive compulsive disorder patients non-respondent to first line pharmacological treatment. The investigators will compare: fluoxetine maintenance at maximum dosage for additional 12 weeks; the association of fluoxetine with quetiapine; and the association of fluoxetine with clomipramine.
NCT00564564	Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-Compulsive Disorder Patients	Completed	Conselho Nacional de Desenvolvimento Científico e Tecnológico	Phase 4	2006-01-01	The objective of this trial is to compare in an open trial format the efficacy of association of clomipramine and quetiapine with SSRI after SSRI treatment failed to produce complete remission of obsessive compulsive disorder symptoms.

Clinical Trial Conditions for Anafranil

Condition Name

Condition Name for Anafranil
Intervention	Trials
Obsessive Compulsive Disorder	3
Depression	2
Sciatica	1
Major Depression	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Anafranil
Intervention	Trials
Obsessive-Compulsive Disorder	3
Disease	3
Compulsive Personality Disorder	3
Compulsive Behavior	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Anafranil

Trials by Country

Trials by Country for Anafranil
Location	Trials
Brazil	2
United States	1
Canada	1
Israel	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Anafranil
Location	Trials
California	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Anafranil

Clinical Trial Phase

Clinical Trial Phase for Anafranil
Clinical Trial Phase	Trials
Phase 4	2
Phase 2	1
Phase 1	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Anafranil
Clinical Trial Phase	Trials
Completed	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Anafranil

Sponsor Name

Sponsor Name for Anafranil
Sponsor	Trials
Sandoz	2
University of Sao Paulo	2
Conselho Nacional de Desenvolvimento Científico e Tecnológico	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Anafranil
Sponsor	Trials
Other	12
Industry	3
U.S. Fed	1

Export unavailable in trial.
Subscribe for complete access.